Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers

Abstract

The invention relates to the nucleic acid of a novel human MATK-related variant (MATKV) and the polypeptides encoded thereby. The invention also provides a process for producing the polypeptide encoded by MATKV. The invention further provides the uses of the nuclei acid of MATKV and the polypeptide encoded thereby in diagnosing the disease associated with the deficiency of human MATK gene, in particular lung cancers, preferably small cell lung cancers.

Dependencies are inferred from the claim text.